Published : Oct-2017
No. of Pages : 507
1 Table of Contents 2
1.1 List of Tables 12
1.2 List of Figures 20
2 Introduction 21
2.1 Women's Health Devices Overview 21
3 Products under Development 22
3.1 Women's Health Devices - Pipeline Products by Stage of Development 22
3.2 Women's Health Devices - Pipeline Products by Territory 23
3.3 Women's Health Devices - Pipeline Products by Regulatory Path 25
3.4 Women's Health Devices - Pipeline Products by Estimated Approval Date 26
3.5 Women's Health Devices - Ongoing Clinical Trials 27
4 Women's Health Devices - Pipeline Products under Development by Companies 28
4.1 Women's Health Devices Companies - Pipeline Products by Stage of Development 28
4.2 Women's Health Devices - Pipeline Products by Stage of Development 33
5 Women's Health Devices Companies and Product Overview 38
5.1 Acelity L.P. Inc. Company Overview 38
5.2 Advanced Prenatal Therapeutics, Inc. Company Overview 39
5.3 Advanced Tactile Imaging Inc Company Overview 40
5.4 Aethlon Medical Inc Company Overview 43
5.5 Agile Therapeutics Inc Company Overview 44
5.6 Allergan Plc Company Overview 48
5.7 AltaScience Limited Company Overview 51
5.8 Amniotix Technologies Ltd Company Overview 52
5.9 Aneeve Nanotechnologies LLC Company Overview 53
5.10 atTerm Medical Company Overview 54
5.11 Babyation LLC Company Overview 55
5.12 Bayer AG Company Overview 56
5.13 Bayer HealthCare AG (Inactive) Company Overview 58
5.14 Baylor College of Medicine Company Overview 59
5.15 Baystate Medical Center Company Overview 60
5.16 Becton Dickinson and Co Company Overview 61
5.17 Bioceptive Inc Company Overview 62
5.18 BioResonator Good Eye AB Company Overview 63
5.19 Biorings LLC Company Overview 64
5.20 Biostruxs LLC Company Overview 65
5.21 Birmont Medical Ltd. Company Overview 66
5.22 Boston Scientific Corp Company Overview 67
5.23 Cambridge Design Partner Ltd. Company Overview 69
5.24 Cath Med Ltd. Company Overview 70
5.25 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 71
5.26 CervoCheck, LLC Company Overview 72
5.27 CommonSense Ltd. Company Overview 73
5.28 Concepta Diagnostic Ltd Company Overview 74
5.29 Conrad Company Overview 75
5.30 Contramed LLC Company Overview 76
5.31 CrossBay Medical, Inc. Company Overview 80
5.32 Dare Bioscience Inc Company Overview 81
5.33 Dartmouth College Company Overview 82
5.34 Discreet Secrete Solutions Company Overview 84
5.35 Drexel University Company Overview 85
5.36 DS Labs, Inc Company Overview 86
5.37 Elucent Medical Inc Company Overview 87
5.38 Enox Biopharma Inc Company Overview 89
5.39 Ethicon US LLC Company Overview 90
5.40 EVE Medical Systems Ltd Company Overview 91
5.41 Evestra Inc Company Overview 92
5.42 Evofem Inc Company Overview 93
5.43 ExploraMed NC7 Inc Company Overview 95
5.44 Femasys Inc Company Overview 96
5.45 FemSuite LLC Company Overview 100
5.46 Ferring Pharmaceuticals A/S Company Overview 102
5.47 Fibro Control (Israel) Ltd (Inactive) Company Overview 103
5.48 Galmedics Biotech Ltd Company Overview 104
5.49 Global Health Partnerships Company Overview 105
5.50 Gynesonics Inc Company Overview 106
5.51 Healingstone Co Ltd Company Overview 109
5.52 Healthcare Enterprise Group PLC (Inactive) Company Overview 110
5.53 Hong Kong Polytechnic University Company Overview 111
5.54 Igantia Therapeutics Company Overview 112
5.55 Impres Medical, Inc. Company Overview 113
5.56 In Veritas Medical Diagnostics Inc. (Inactive) Company Overview 114
5.57 Innometrix Company Overview 115
5.58 Innovus Pharmaceuticals Inc Company Overview 116
5.59 Inpress Technologies, Inc. Company Overview 117
5.60 Janitri Innovations Pvt Ltd Company Overview 118
5.61 Jibon Health Technologies, Inc. Company Overview 119
5.62 John Hopkins University Company Overview 122
5.63 Joylux Inc Company Overview 124
5.64 Kerecis ehf Company Overview 127
5.65 KynderMed Inc Company Overview 128
5.66 Laboratoire HRA Pharma Company Overview 129
5.67 Laboratorios Andromaco Company Overview 131
5.68 Madorra Company Overview 132
5.69 Materna Medical Inc. Company Overview 133
5.70 Mayo Clinic in Rochester Company Overview 134
5.71 McNEIL-PPC Inc Company Overview 135
5.72 Medela AG Company Overview 138
5.73 MEDITE Cancer Diagnostics Inc Company Overview 139
5.74 Medprin Regenerative Medical Technologies Co Ltd Company Overview 140
5.75 Mentor Worldwide LLC Company Overview 141
5.76 Merck & Co Inc Company Overview 142
5.77 Merck KGaA Company Overview 143
5.78 Merck Serono SA Company Overview 145
5.79 Microchips Biotech Inc Company Overview 147
5.80 Mithra Pharmaceuticals SA Company Overview 148
5.81 Momtec Life Ltd. Company Overview 150
5.82 Nipro Corp Company Overview 151
5.83 Northwestern University Company Overview 153
5.84 Novela Inc Company Overview 156
5.85 Novomedics L L C Company Overview 157
5.86 Nuveta, Inc. Company Overview 158
5.87 Nvision Medical Corporation Company Overview 159
5.88 OB Smart Ltd Company Overview 161
5.89 OCON Medical Ltd Company Overview 162
5.90 OmniBiome Therapeutics Inc (Inactive) Company Overview 166
5.91 OncoGenesis Company Overview 167
5.92 Ondine Biomedical Inc Company Overview 168
5.93 Onko Solutions, LLC Company Overview 169
5.94 OptiVia Medical, LLC Company Overview 170
5.95 ORATEL DIAGNOSTICS LLC Company Overview 171
5.96 Os Technology LLC Company Overview 172
5.97 Pfizer Inc Company Overview 173
5.98 Polytechnic University of Catalonia Company Overview 174
5.99 Positive Care Ltd Company Overview 175
5.100 Rambam Health Care Campus Company Overview 176
5.101 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 177
5.102 RevMedx, Inc. Company Overview 179
5.103 Rice University Company Overview 180
5.104 Shift Labs, Inc. Company Overview 181
5.105 Soulor Surgical Inc (Inactive) Company Overview 182
5.106 Stanford University Company Overview 183
5.107 Strata Various Product Design Company Overview 184
5.108 Tecuro AG Company Overview 185
5.109 Tentan AG Company Overview 186
5.110 TeVido BioDevices, LLC Company Overview 189
5.111 The Cooper Companies Inc Company Overview 191
5.112 The Feinstein Institute for Medical Research Company Overview 192
5.113 The Pennsylvania State University Company Overview 193
5.114 TruScreen Ltd Company Overview 194
5.115 University of Auckland Company Overview 196
5.116 University of California San Francisco Company Overview 197
5.117 University of Florida Company Overview 198
5.118 University of Liverpool Company Overview 201
5.119 University of Maryland Baltimore Company Overview 204
5.120 University of Minnesota Company Overview 205
5.121 University of Sheffield Company Overview 206
5.122 University of South Florida Company Overview 207
5.123 University of Southern California Company Overview 210
5.124 University of Texas Health Science Center at San Antonio Company Overview 211
5.125 University of the Witwatersrand Company Overview 212
5.126 University of Washington Company Overview 213
5.127 Virginia Commonwealth University Company Overview 214
5.128 ZR-Operculum, Inc. Company Overview 215
6 Women's Health Devices - Recent Developments 216
6.1 Sep 21, 2017: Mithra Announces 2017 Half Year Results 216
6.2 Sep 20, 2017: Innovus Pharma's Partner Luminarie Receives Approval for Zestra for Female Sexual Arousal Disorder as a Medical Device I from New Zealands Medicines and Medical Devices Safety Authority 216
6.3 Sep 18, 2017: Juniper Pharmaceuticals Announces Strategic Reprioritization 217
6.4 Sep 12, 2017: Wolfgang Nickl to be new Chief Financial Officer at Bayer 219
6.5 Sep 11, 2017: EKF Diagnostics Holdings: Half Yearly Report 219
6.6 Sep 11, 2017: Merck Names Heidi Fagerholm as New Head of Advanced Technologies 220
6.7 Sep 11, 2017: The Allergan Foundation to Donate $150,000 to Support Hurricane Irma Relief Efforts 220
6.8 Sep 11, 2017: Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors 220
6.9 Sep 08, 2017: Fresenius Kabi marks 20-year anniversary of Friedberg production site - Logistics center expansion planned 221
6.10 Sep 07, 2017: Agile Therapeutics to Present Additional Phase 3 Data at the 73rd Annual Congress of the American Society for Reproductive Medicine 222
6.11 Sep 07, 2017: Bayer again listed in the Dow Jones Sustainability World Index 222
6.12 Sep 06, 2017: Dr. Francisco Arredondo Opens First U.S. Invocell Center in McAllen, Texas 222
6.13 Sep 05, 2017: Merck Prepares Strategic Options for the Consumer Health Business 223
6.14 Aug 31, 2017: The Cooper Companies Announces Third Quarter 2017 Results 224
6.15 Aug 24, 2017: New Study Reports Superior Clinical Outcomes Utilising L-Dex 224
6.16 Aug 24, 2017: Lee's Pharmaceutical Holdings: Interim Results For The Six Months Ended 30 June 2017 225
6.17 Aug 23, 2017: Concepta makes first shipment of myLotus fertility product to China 228
6.18 Aug 23, 2017: ImpediMed: Financial Year Ended 30 June 2017 228
6.19 Aug 23, 2017: Concepta appoints Zhang Zhi Gang, as Head of China Operations 229
6.20 Aug 22, 2017: Bayer will continue to work constructively with the European Commission 230
6.21 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson 230
6.22 Aug 17, 2017: Conceivex and HealthWarehouse.com Sign National Distribution Agreement 230
6.23 Aug 16, 2017: Coloplast delivers satisfactory Q3 result 231
6.24 Aug 15, 2017: Ava Fertility Tracking Bracelet Announces Arrival of First Baby Conceived Using Device 232
6.25 Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results 233
6.26 Aug 14, 2017: Atossa Genetics Announces Second Quarter 2017 Financial Results And Provides Company Update 235
6.27 Aug 10, 2017: Aethlon Medical Announces Fiscal 2018 First Quarter Results 235
6.28 Aug 10, 2017: Invo Bioscience Reports Record Second Quarter 2017 Financial Results 237
6.29 Aug 09, 2017: HARTMANN GROUP is investing in the future 238
6.30 Aug 09, 2017: Sientra Reports Second Quarter 2017 Financial Results 239
6.31 Aug 06, 2017: FDA Approves Medicines360's sNDA for LILETTA (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years 240
6.32 Aug 03, 2017: INVOcell Fertility Treatment now Offered at the Center for Reproductive Health at Tri-Star Centennial Medical Center in Nashville 241
6.33 Aug 03, 2017: Dare Bioscience Discusses Key Goals with Wall Street Analyzer 242
6.34 Aug 03, 2017: Earth Science Tech Signs Contract with Absolu to Advance Phase-2 Rollout on MSN-2 Medical Device 242
6.35 Aug 03, 2017: Q2 2017: Merck Sets Course for Future Growth 243
6.36 Aug 03, 2017: Executive Board Changes at Merck 245
6.37 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter 246
6.38 Aug 03, 2017: Juniper Pharmaceuticals Reports Second Quarter 2017 Financial and Operating Results 248
6.39 Aug 03, 2017: Allergan Reports Continued Strong Execution in Second Quarter 2017 with 9% Increase in GAAP Net Revenues to $4.0 Billion 249
6.40 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 253
6.41 Aug 02, 2017: CRH Medical Announces Results for the Three and Six Months Ended June 30, 2017 254
6.42 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 256
6.43 Aug 01, 2017: Piedmont Reproductive Endocrinology Group in South Carolina Successfully Launches INVOcell 258
6.44 Jul 27, 2017: Agile Therapeutics Announces FDA Acceptance Of The NDA Resubmission Of Twirla 259
6.45 Jul 27, 2017: McKesson Reports Fiscal 2018 First-Quarter Results 259
6.46 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 260
6.47 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 262
6.48 Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results 264
6.49 Jul 25, 2017: Utah Medical Products Reports Financial Performance for Second Quarter 2017 266
6.50 Jul 24, 2017: Dare Bioscience announces Memorandum of Understanding with CONRAD for the conduct of the Ovaprene postcoital test clinical trial 269
6.51 Jul 24, 2017: New Potential Approach to Treating Postpartum Hemorrhage 270
6.52 Jul 24, 2017: APPENDIX 4C - Quarter Ended 30 June 2017 271
6.53 Jul 21, 2017: Merck Opens New Application Laboratory in Shanghai 272
6.54 Jul 20, 2017: Innovus Pharma's Partner Luminarie Receives Approval for Zestra for Female Sexual Arousal Disorder as a Medical Device I from Australia's Therapeutic Goods Administration 273
6.55 Jul 19, 2017: Houston Fertility Center To Begin Offering Invocell Procedure To Patients In Southeast Texas 274
6.56 Jul 19, 2017: Joseph H. Boccuzi Appointed to Allergan Board of Directors 274
6.57 Jul 17, 2017: Mithra Submits Myring For European Marketing Approval 275
6.58 Jul 14, 2017: Vitrolife: Interim report January-June 2017: Successes in Asia and in Time-lapse 275
6.59 Jul 12, 2017: Merck Refines Western European Life Science Production Site Network 276
6.60 Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 276
6.61 Jul 11, 2017: M Pharmaceutical Provides Update on FDA Cleared OTC Product, ToConceive 277
6.62 Jul 11, 2017: Dr. Echenberg Announces VuVaTech's New Safe and Effective At-Home VuVa Magnetic Dilator Therapy Program to Treat Painful Intercourse 278
6.63 Jul 06, 2017: NICE Develops a Medtech Innovation Briefing on L-Dex U400 for Lymphoedema After Breast Cancer Treatment 278
6.64 Jul 06, 2017: Fresenius Kabi expands production site in Portugal 279
7 Appendix 502
7.1 Methodology 502
7.2 About GlobalData 505
7.3 Contact Us 505
7.4 Disclaimer 505
1.1 List of Tables
Table 1: Women's Health Devices - Pipeline Products by Stage of Development 24
Table 2: Women's Health Devices - Pipeline Products by Territory 26
Table 3: Women's Health Devices - Pipeline Products by Regulatory Path 27
Table 4: Women's Health Devices - Pipeline Products by Estimated Approval Date 28
Table 5: Women's Health Devices - Ongoing Clinical Trials 29
Table 6: Women's Health Devices Companies - Pipeline Products by Stage of Development 30
Table 7: Women's Health Devices - Pipeline Products by Stage of Development 35
Table 8: Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 9: Strattice For Lumpectomy Reconstruction - Product Status 40
Table 10: Strattice For Lumpectomy Reconstruction - Product Description 40
Table 11: Advanced Prenatal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 12: Targeted Apheresis Cartridge For Preeclampsia - Product Status 41
Table 13: Targeted Apheresis Cartridge For Preeclampsia - Product Description 41
Table 14: Advanced Tactile Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 15: Cervix Monitor - Product Status 42
Table 16: Cervix Monitor - Product Description 42
Table 17: Advanced Tactile Imaging Inc - Ongoing Clinical Trials Overview 43
Table 18: Cervix Monitor - Cervix Monitor for Risk Assessment of Spontaneous Preterm Delivery 44
Table 19: Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 20: HER2osome - Product Status 45
Table 21: HER2osome - Product Description 45
Table 22: Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Table 23: AG200-ER Patch - Product Status 46
Table 24: AG200-ER Patch - Product Description 47
Table 25: AG200-SP Patch - Product Status 47
Table 26: AG200-SP Patch - Product Description 47
Table 27: AG890 Patch - Product Status 48
Table 28: AG890 Patch - Product Description 48
Table 29: Twirla (AG200-15) - Product Status 48
Table 30: Twirla (AG200-15) - Product Description 49
Table 31: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 32: LILETTA - 5 Years - Product Status 50
Table 33: LILETTA - 5 Years - Product Description 51
Table 34: Norethindrone Transdermal Delivery System - Product Status 51
Table 35: Norethindrone Transdermal Delivery System - Product Description 51
Table 36: Vaginal Ring Contraceptive - Product Status 52
Table 37: Vaginal Ring Contraceptive - Product Description 52
Table 38: AltaScience Limited Pipeline Products & Ongoing Clinical Trials Overview 53
Table 39: AltaSeal - Product Status 53
Table 40: AltaSeal - Product Description 53
Table 41: Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
Table 42: Amniotic Fluid Spectral Monitoring Device - Product Status 54
Table 43: Amniotic Fluid Spectral Monitoring Device - Product Description 54
Table 44: Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview 55
Table 45: Hormone Level Monitor - Product Status 55
Table 46: Hormone Level Monitor - Product Description 55
Table 47: atTerm Medical Pipeline Products & Ongoing Clinical Trials Overview 56
Table 48: OBSPRING - Product Status 56
Table 49: OBSPRING - Product Description 56
Table 50: Babyation LLC Pipeline Products & Ongoing Clinical Trials Overview 57
Table 51: Babyation Pump - Product Status 57
Table 52: Babyation Pump - Product Description 57
Table 53: Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 58
Table 54: Kyleena - Product Status 58
Table 55: Kyleena - Product Description 59
Table 56: Next-Generation Essure Device - Product Status 59
Table 57: Next-Generation Essure Device - Product Description 59
Table 58: Bayer HealthCare AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 60
Table 59: LNG-IUS16 - Product Status 60
Table 60: LNG-IUS16 - Product Description 60
Table 61: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 61
Table 62: 3D Printed Pediatric Vaginal Stent - Product Status 61
Table 63: 3D Printed Pediatric Vaginal Stent - Product Description 61
Table 64: Baystate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 62
Table 65: Expandable Pessaries - Product Status 62
Table 66: Expandable Pessaries - Product Description 62
Table 67: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 63
Table 68: Odon Device - Product Status 63
Table 69: Odon Device - Product Description 63
Table 70: Bioceptive Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 71: Intrauterine Device Inserter - Product Status 64
Table 72: Intrauterine Device Inserter - Product Description 64
Table 73: BioResonator Good Eye AB Pipeline Products & Ongoing Clinical Trials Overview 65
Table 74: Breast Checker - Product Status 65
Table 75: Breast Checker - Product Description 65
Table 76: Biorings LLC Pipeline Products & Ongoing Clinical Trials Overview 66
Table 77: Vaginal Ring - Product Status 66
Table 78: Vaginal Ring - Product Description 66
Table 79: Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 67
Table 80: BioBreast Scaffold - Product Status 67
Table 81: BioBreast Scaffold - Product Description 67
Table 82: Birmont Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
Table 83: Labor Progression Monitoring Device - Product Status 68
Table 84: Labor Progression Monitoring Device - Product Description 68
Table 85: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 69
Table 86: AUB Derivative Device - Product Status 69
Table 87: AUB Derivative Device - Product Description 69
Table 88: Obtryx System-Minimal Mesh Anterior-Apical Prolapse Repair - Product Status 70
Table 89: Obtryx System-Minimal Mesh Anterior-Apical Prolapse Repair - Product Description 70
Table 90: Cambridge Design Partner Ltd. Pipeline Products & Ongoing Clinical Trials Overview 71
Table 91: Uterine Balloon Tamponade - Product Status 71
Table 92: Uterine Balloon Tamponade - Product Description 71
Table 93: Cath Med Ltd. Pipeline Products & Ongoing Clinical Trials Overview 72
Table 94: Chorionic Villus Sampling Trans-Cervical Catheter - Product Status 72
Table 95: Chorionic Villus Sampling Trans-Cervical Catheter - Product Description 72
Table 96: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73
Table 97: CeraShield Intravaginal Silicone Ring - Product Status 73
Table 98: CeraShield Intravaginal Silicone Ring - Product Description 73
Table 99: CervoCheck, LLC Pipeline Products & Ongoing Clinical Trials Overview 74
Table 100: CervoCheck - Product Status 74
Table 101: CervoCheck - Product Description 74
Table 102: CommonSense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 75
Table 103: Sensing Tampons - Women - Product Status 75
Table 104: Sensing Tampons - Women - Product Description 75
Table 105: Concepta Diagnostic Ltd Pipeline Products & Ongoing Clinical Trials Overview 76
Table 106: myLotus Meter - Product Status 76
Table 107: myLotus Meter - Product Description 76
Table 108: Conrad Pipeline Products & Ongoing Clinical Trials Overview 77
Table 109: Triple Protection Vaginal Ring - Product Status 77
Table 110: Triple Protection Vaginal Ring - Product Description 77
Table 111: Contramed LLC Pipeline Products & Ongoing Clinical Trials Overview 78
Table 112: LevoCept - Product Status 78
Table 113: LevoCept - Product Description 78
Table 114: VeraCept - Product Status 79
Table 115: VeraCept - Product Description 79
Table 116: Contramed LLC - Ongoing Clinical Trials Overview 80
Table 117: VeraCept - Evaluation of the Effectiveness, Safety and Tolerability of the ContraMed VeraCept Intrauterine Copper Contraceptive for Long-Acting Reversible Contraception 81
Table 118: CrossBay Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
Table 119: CrossBay IVF Embryo Transfer Catheter Set - Product Status 82
Table 120: CrossBay IVF Embryo Transfer Catheter Set - Product Description 82
Table 121: Dare Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 83
Table 122: Ovaprene - Product Status 83
Table 123: Ovaprene - Product Description 83
Table 124: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 84
Table 125: Magnetic Particle Heating System - Product Status 84
Table 126: Magnetic Particle Heating System - Product Description 84
Table 127: Nanotherapeutic Device - Product Status 85
Table 128: Nanotherapeutic Device - Product Description 85
Table 129: Discreet Secrete Solutions Pipeline Products & Ongoing Clinical Trials Overview 86
Table 130: Freedom Pump - Product Status 86
Table 131: Freedom Pump - Product Description 86
Table 132: Drexel University Pipeline Products & Ongoing Clinical Trials Overview 87
Table 133: Belly Band - Product Status 87
Table 134: Belly Band - Product Description 87
Table 135: DS Labs, Inc Pipeline Products & Ongoing Clinical Trials Overview 88
Table 136: Gala Pump - Product Status 88
Table 137: Gala Pump - Product Description 88
Table 138: Elucent Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 89
Table 139: EnVisio - Product Status 89
Table 140: EnVisio - Product Description 89
Table 141: SmartClip - Product Status 89
Table 142: SmartClip - Product Description 90
Table 143: Enox Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 91
Table 144: Intra Vaginal Device - Product Status 91
Table 145: Intra Vaginal Device - Product Description 91
Table 146: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 92
Table 147: Gynecare GynOcclude - Product Status 92
Table 148: Gynecare GynOcclude - Product Description 92
Table 149: EVE Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 93
Table 150: EVE System - Premenstrual Syndrome - Product Status 93
Table 151: EVE System - Premenstrual Syndrome - Product Description 93
Table 152: Evestra Inc Pipeline Products & Ongoing Clinical Trials Overview 94
Table 153: Progestin Vaginal Ring - Product Status 94
Table 154: Progestin Vaginal Ring - Product Description 94
Table 155: Evofem Inc Pipeline Products & Ongoing Clinical Trials Overview 95
Table 156: Amphora - Product Status 95
Table 157: Amphora - Product Description 95
Table 158: Nestorone/Ethinyl estradiol (NES/EE) Contraceptive Vaginal Ring (CVR) - Product Status 96
Table 159: Nestorone/Ethinyl estradiol (NES/EE) Contraceptive Vaginal Ring (CVR) - Product Description 96
Table 160: ExploraMed NC7 Inc Pipeline Products & Ongoing Clinical Trials Overview 97
Table 161: Willow Breast Pump - Product Status 97
Table 162: Willow Breast Pump - Product Description 97
Table 163: Femasys Inc Pipeline Products & Ongoing Clinical Trials Overview 98
Table 164: FemaSeed Insemination Catheter - Product Status 98
Table 165: FemaSeed Insemination Catheter - Product Description 98
Table 166: FemBloc - Product Status 99
Table 167: FemBloc - Product Description 99
1.2 List of Figures
Figure 1: Women's Health Devices - Pipeline Products by Stage of Development 24
Figure 2: Women's Health Devices - Pipeline Products by Territory 25
Figure 3: Women's Health Devices - Pipeline Products by Regulatory Path 27
Figure 4: Women's Health Devices - Pipeline Products by Estimated Approval Date 28
Figure 5: Women's Health Devices - Ongoing Clinical Trials 29
